Academic literature on the topic 'Health products'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Health products.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Health products"

1

Goldman, Ran D., Alex L. Rogovik, David Lai, and Sunita Vohra. "Potential Interactions of Drug–Natural Health Products and Natural Health Products–Natural Health Products among Children." Journal of Pediatrics 152, no. 4 (April 2008): 521–26. http://dx.doi.org/10.1016/j.jpeds.2007.09.026.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Fallis, Jordan. "Natural health products." Canadian Pharmacists Journal / Revue des Pharmaciens du Canada 146, no. 2 (March 2013): 65–66. http://dx.doi.org/10.1177/1715163513482714.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Nathan, Alan. "Oral health products." Primary Health Care 6, no. 6 (June 1988): 12–13. http://dx.doi.org/10.7748/phc.6.6.12.s8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Nahas, Richard, and Jeannette Goguen. "Natural Health Products." Canadian Journal of Diabetes 37 (April 2013): S97—S99. http://dx.doi.org/10.1016/j.jcjd.2013.01.029.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Akintomide, Hannat. "Advertising sexual health products." Journal of Family Planning and Reproductive Health Care 36, no. 1 (January 1, 2010): 45. http://dx.doi.org/10.1783/147118910790290920.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Lashof, J. C. "Regulating Natural Health Products." Science 296, no. 5565 (April 5, 2002): 46b—47. http://dx.doi.org/10.1126/science.296.5565.46b.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Bartkowiak-Wieczorek, Joanna, and Edyta Mądry. "Natural Products and Health." Nutrients 16, no. 3 (January 31, 2024): 415. http://dx.doi.org/10.3390/nu16030415.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

M Ames, J. "Dietary Maillard Reaction Products: Implications for Human Health and Disease." Czech Journal of Food Sciences 27, Special Issue 1 (June 24, 2009): S66—S69. http://dx.doi.org/10.17221/624-cjfs.

Full text
Abstract:
When foods are heat processed, the sugars and lipids react with the proteins they contain via the Maillard and related reactions to form a wide range of products. As a result, the sensory, safety, nutritional and health-promoting attributes of the foods are affected. Reaction products include advanced glycation/lipoxidation endproducts (AGE/ALEs), acrylamide and heterocyclic amines (HAA), all of which may impact on human health and disease. Furthermore, some Maillard reaction products affect the growth of colonic bacteria and thermally-induced modification of dietary protein can affect allergenicity. This paper briefly reviews aspects of the Maillard reaction in food related to human health.
APA, Harvard, Vancouver, ISO, and other styles
9

Michele, Rasoloharimahefa Rasamoela, and Catherine Bouland. "Health effects of chemical products: cleaning products and biocides." ISEE Conference Abstracts 2013, no. 1 (September 19, 2013): 5201. http://dx.doi.org/10.1289/isee.2013.p-3-30-07.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Wu, Christine D. "Grape Products and Oral Health." Journal of Nutrition 139, no. 9 (July 29, 2009): 1818S—1823S. http://dx.doi.org/10.3945/jn.109.107854.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Dissertations / Theses on the topic "Health products"

1

Casas, Ruiz Lidia 1978. "Microbial exposures, cleaning products and child health." Doctoral thesis, Universitat Pompeu Fabra, 2013. http://hdl.handle.net/10803/133453.

Full text
Abstract:
Background and aims: The immune, respiratory and central nervous system start developing during pregnancy and continue during the first years of life. Therefore, environmental exposures during these periods may play a role on the maturation of these systems. In particular, the exposure to indoor microbial agents, indoor factors such as pets or dampness, and to household cleaning products during infancy or childhood may have important implications in the development processes. This thesis aims to assess the long term effects of indoor exposure to microbial agents and chemical based cleaning products on respiratory and mental health among children from birth to the age of 13 years old. Methods: We used data from nine European birth cohorts that are part of three projects: the European HITEA project, the Spanish INMA project; and the German GINIplus and LISAplus birth cohort studies. Information on the exposure to indoor dampness, pet ownership, the use of cleaning products and allergy and respiratory health was periodically collected through questionnaires and health tests. Living room dust samples were collected when the children were 2-3 months and analysed for microbial agents concentrations (bacterial endotoxin, fungal extracellular polysaccharides (EPS) from Aspergillus spp. and Penicillium spp, and mould β(1,3)- glucans). Multivariable regression models were used to assess the associations between the exposures and the health outcomes. Results: 1) Concentrations of measured microbial agents varied differently across the cohorts. 2) Season of dust sampling, dog ownership, indoor report of dampness, and number of people living in the home is associated with the concentrations of microbial agents. 3) Early life exposure to endotoxin and dogs in the home is associated with lower levels of FeNO at school age. 4) Domestic use of cleaning sprays, air fresheners and solvents during pregnancy is associated with a higher prevalence of wheezing and LRTI during the first year of life. 5) At school age, bystander exposure to domestic cleaning sprays increases the levels of FeNO, and exposure to air freshening sprays and solvents decreases the lung function. 6) Persistent exposure to indoor dampness during early life has negative effects on the cognitive function and social competences at 4 years old. 7) Exposure to visible mould, dampness and pet ownership during the first 10 years of life increases the risk of borderline or abnormal scores in the SDQ at 10 years of age. Conclusion: Our results suggest that indoor exposure to microbial agents during early life and exposure to chemical based cleaning products during pregnancy, infancy and childhood play a role in the development of the respiratory, immune and central nervous systems.
Introducció i objectius: El desenvolupament dels sistemes immunitari, respiratori i nerviós central comença durant l’embaràs i continua al llarg la infància. Així, els primers anys de vida són moments crucials en que qualsevol exposició ambiental pot influir el desenvolupament d’aquests sistemes. Concretament, l’exposició durant la infància a agents microbiològics, humitat, animals de companyia i productes de neteja pot tenir implicacions importants en els processos de maduració d’aquests sistemes. L’objectiu principal d’aquesta tesi és el d’avaluar els efectes a llarg termini de la exposició a agents microbiològics i a productes de neteja de base química a la llar, sobre la salut respiratòria i mental des del naixement fins a l’edat de 13 anys. Mètodes: En aquesta tesi hem fet servir dades de nou cohorts de naixement europees que formen part de tres projectes: el projecte europeu HITEA, el projecte espanyol INMA, i els estudis alemanys GINIplus i LISAplus. La informació sobre la exposició a humitat, a animals de companyia, la utilització de productes de neteja, al·lèrgies i salut respiratòria es va recollir en tots els projectes mitjançant qüestionaris administrats als pares/mares i proves mèdiques o tests neuropsicològics. A més, es van recollir mostres de pols dels menjadors de les cases quan els nens/es tenien 2-3 mesos d’edat que es van analitzar per determinar les concentracions d’agents microbiològics (endotoxines bacterianes, polisacàrids extracel·lulars (EPS) d’Aspergillus spp. i Penicillium spp i β(1,3)-glucans fúngics). Per l’avaluació de les associacions entre exposicions i resultats de salut s’han desenvolupat models de regressió múltiple. Resultats: 1) Les concentracions d’agents microbiològics mesurats en pols de les llars varien per cohort. 2) L’estació de l’any en que es recull la mostra de pols, la presència de gossos a la casa, reportar humitat a la casa i el número de persones que hi viuen estan associats amb la concentració d’agents microbiològics a la pols. 3) L’exposició durant els primers mesos de vida a endotoxines i gossos a la llar s’associa amb nivells baixos de FeNO a edat escolar. 4) L’ús d’esprais i dissolvents per la neteja de la casa, i ambientadors durant l’embaràs està relacionat amb un increment en la prevalença de sibilants i infeccions respiratòries de vies baixes al llarg del primer any de vida. 5) En edat escolar, la exposició passiva a productes de neteja domèstics utilitzats en forma d’esprais incrementa els nivells de FeNO, i l’exposició a esprais ambientadors i dissolvents per la neteja de la llar disminueix la funció pulmonar. 6) L’exposició persistent a humitat a la llar durant els 2 primers anys de vida té un efecte negatiu sobre la funció cognitiva i les competències socials mesurades als 4 anys d’edat. 7) L’exposició a fongs procedents de la humitat, a humitat i a animals de companyia a casa al llarg dels primers 10 anys de vida incrementa el risc de puntuacions “borderline” o anormals al questionari SDQ administrat als 10 anys. Conclusió: els resultats presentats en aquesta tesi suggereixen que l’exposició a agents microbiològics durant els primers mesos de vida i l’exposició a productes de neteja durant l’embaràs i la infància juguen un paper important en el desenvolupament dels sistemes respiratori, immunològic i nerviós central.
APA, Harvard, Vancouver, ISO, and other styles
2

McAuley, Kimberley. "Disinfection by-products and public health concerns." University of Western Australia. School of Population Health, 2009. http://theses.library.uwa.edu.au/adt-WU2009.0070.

Full text
Abstract:
Disinfection by-products (DBPs) are a major group of water contaminants and their role in causing adverse health outcomes, including adverse pregnancy outcomes, endocrine disruption, respiratory related adverse health outcomes and cancer has been subject to extensive epidemiological and toxicological research and review. Determination of safe exposure to DBPs, particularly within drinking water supplies, has been a topic of extensive debate, with a wide range of acceptable levels set across the industrialized world. The focus of the research in this thesis was on two of the main health outcomes associated with DBP exposure, namely adverse pregnancy outcomes and asthma related symptoms. To assess adverse pregnancy outcomes in Perth, an extensive classification quantification of the major DBPs in Perth drinking water was conducted. A registrybased prevalence study was carried out to assess birth defects in relation to high, medium and low DBP areas (defined by the water sampling and analysis). It was found that women living in high THM areas are 22% (odds ratio (OR) 1.22, 95% confidence interval (95% CI) 1.01-1.48) more likely of having a baby with any birth defect. High exposure was also strongly associated with an increased risk of having a baby with a cardiovascular defect (62% increased risk). Low birth weight and prematurity were also assessed; however these outcomes were not associated with an increased risk through an increase in exposure. Following on from this analysis, a population risk assessment model was developed for DBPs in high exposure environments. This involved a three step process: (i) Firstly a questionnaire-based validation and reliability study was used to assess water consumption patterns of a population of pregnant women in Perth. (ii) Secondly a prediction model for teratogenic burden of DBPs in Perth was developed, related to the exposure patterns of the population of pregnant women involved in the validation and reliability study. (iii) Finally, combining the information collected in (i) and (ii), along with the regression slope estimates for birth weight from the prevalence study (defined in Section 2.2.1), a dose-response model for THMs and birth weight was developed. Predictive simulations for birth weights at given THM levels were then conducted. It was estimated that pregnant women in Perth are exposed to between 0.3 – 4.10 µg/day ingested TTHM, and of this, the more toxic brominated forms accounted for between 0.27 – 3.69 µg/day. Based on a dose-response model used, birthweights calculated for the ‘hypothetical’ exposures ranged from 3403.2g for the highest exposure to 3503.5g in the lowest exposure, which is a difference of over 100g. Although the resulting reduction in birth weight is not extreme, there is still a significant reduction in birth weight present as exposure to TTHMs increases. This is the first doseresponse model to be developed to assess an adverse pregnancy outcome based on pregnant women exposure data, and will be a useful tool for assessing varying exposures throughout not only Australia but also throughout the industrialised world, where DBP exposure is highly prevalent.
APA, Harvard, Vancouver, ISO, and other styles
3

Cunha, Ricardo Filipe Soares Alves. "Research and development strategy on health products." Master's thesis, Universidade de Aveiro, 2012. http://hdl.handle.net/10773/10484.

Full text
Abstract:
Mestrado em Biomedicina Farmacêutica
Este relatório descreve a minha experiência de nove meses como estagiário no departamento de Investigação, Desenvolvimento e Inovação na Eurotrials Scientific Consultants, uma empresa dedicada à investigação clínica e consultoria científica. A Indústria Farmacêutica tem trabalhado para aumentar a produtividade face ao aumento dos custos de desenvolvimento de novos fármacos, diminuição das previsões de receita e aumento do número de compostos a falhar em estadios tardios do seu desenvolvimento. Para fazer face a estes problemas, as empresas farmacêuticas estão a estabelecer parcerias com a academia e com institutos de investigação. Com este propósito, procurei avaliar quais as áreas de interesse que as Companhias Farmacêuticas e Companhias de Dispositivos Médicos procuram para estabelecer parcerias, desenvolvi projectos de investigação básica com a academia e institutos de investigação e participei em actividades de transferência de tecnologia. Além disso, tive a oportunidade de participar em projectos de investigação clínica nomeadamente em estudos da iniciativa do investigador e também numa formação externa. Em conclusão, o estágio permitiu-me pôr em prática o conhecimento adquirido durante este Mestrado, funcionando como uma ponte entre o mundo académico e o mundo laboral.
This report describes my experience of 9 months as an intern in the department of Research & Development and Innovation at Eurotrials Scientific Consultants, a company dedicated to clinical research and scientific consulting. Pharmaceutical Companies are struggling to deliver improved R&D productivity in the face of rising development costs, stagnating revenue forecasts and continued late stage terminations. In order to increase the number of New Molecular Entities, Pharmaceutical Companies are establishing partnerships with academia and research institutes. With this purpose I researched Pharmaceutical and Medical Devices partnership areas of interest, developed basic research projects with academia and research institutes and participated in technology transfer activities. Furthermore, I had the opportunity to participate in clinical research projects namely investigator driven studies and to be part of an external formation. In conclusion, the training allowed me to put in practice what I learnt in the University, functioning as a bridge between the academic and the working worlds.
APA, Harvard, Vancouver, ISO, and other styles
4

Wong, Po-yin. "Health supplement for aging and the related regulatory issues in Hong Kong an overview /." Click to view the E-thesis via HKUTO, 2008. http://sunzi.lib.hku.hk/hkuto/record/B41712055.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Esposito, Tiziana. "Technologies for the development of health products based on up-cycling of agro-food by-products." Doctoral thesis, Universita degli studi di Salerno, 2019. http://elea.unisa.it:8080/xmlui/handle/10556/4268.

Full text
Abstract:
2017 - 2018
The agro-industrial processing produces large volumes of wastes and by-products. In recent years, wastes and by-products have attracted attention as an excellent renewable source of active compounds with beneficial effects for the human health. However, in that respect a substantial amount of research and complex processes of extraction, characterization and technological transformation are necessary for an efficient use of by-products with the purpose to develop stable and bioactive ingredients for pharmaceutical, food, and nutraceutical products. The main problems for an efficient use are that plant by-products and wastes may be sticky materials, have penetrating smell and unpleasant taste, show critical water solubility and dramatic stability behaviour over time. The present project was aimed to contribute to the zero waste society and country designing and developing new bioactive polymeric particle systems and edible films containing extracts obtained from agro-food wastes and by-products. In particular, the PhD program involved:  Selection of wastes/by-products from Campania agro-industries;  Production, chemical and biological characterization of the extracts from selected wastes/by-products: I) hazelnut shells (HSE), II) hazelnut skins (RHS-H) and III) chestnut spiny burs (CSB-H) polar extracts.  Design, development, technological and biological characterization of new polymeric microparticle systems loaded with HSE.  Design, development and characterization of active edible films loaded with RHS-H and CSB-H and evaluation of their functional efficacy. Polyphenol-rich extracts (HSE, CSB-H, and RHS-H) were produced by exhaustive maceration and Pressurized Liquid Extraction (PLE) from the wastes. The quali/quantitative analysis of the extracts was carried out by chromatographic (Sephadex LH-20, RP-HPLC-DAD, HPLC-HRMS) and spectroscopic techniques (NMR). With the aim to overcome stability and bioavailability problems, new microparticulate powders loaded with the antioxidant and chemopreventive raw HSE extract were produced by spray drying. Pre-formulation studies allowed to select the appropriate multipolymeric matrix composed of coating polymers and loading carriers (proline, medium viscosity hydroxyethyl cellulose, and pectin). The influence of instrumental and operating (temperature, air and fluid flow, pressure, nozzle diameter liquid feed viscosity and pH) process conditions on yield and encapsulation efficiency was evaluated. The produced engineered particles were characterized in terms of active HSE loading (HPLC-DAD), particles dimension (Laser Light Scattering), morphology (SEM and FM), thermal behavior (DSC), water dissolution release (USP II), preservation of bioactivity (DPPH test, MTT assay) and stability under harsh storage conditions (ICH-Guide Lines). The developed HSE particle system is water-soluble, easy handling and functional powder that can be used in topical or oral dosage forms, as adjuvant in the treatment or prevention of melanoma and cervical cancers. CSB-H and RHS-H with antioxidant and antimicrobial activity were used to design an edible pullulan-based films by Casting technique. The effect of extracts on the film mechanical properties, thickness, infrared spectroscopy characteristics (FTIR-ATR), optical properties (UV-Vis transmittance), and biological activity was studied. The developed CSB-H and RHS-H films are shown to be an interesting tool to extend foodstuffs shelf life, being able to protect from the influence of external environmental and biotic factors (oxidative processes and microorganism spoilage). [edited by Author]
XXXI ciclo
APA, Harvard, Vancouver, ISO, and other styles
6

Costa, Sara Filipa Abrantes. "Training in regulatory strategy and regulatory affairs of health products." Master's thesis, Universidade de Aveiro, 2012. http://hdl.handle.net/10773/10587.

Full text
Abstract:
Mestrado em Biomedicina Farmacêutica
O presente relatório descreve as atividades desenvolvidas como estagiária no departamento de Estratégia e Assuntos Regulamentares da empresa Eurotrials, Consultores Científicos, empresa especializada na investigação clínica e consultoria científica na área da saúde. O objetivo principal desta experiência de 9 meses era um primeiro contacto com mundo do trabalho, consolidando e aprofundando os conteúdos abordados no Mestrado em Biomedicina Farmacêutica. Os Assuntos Regulamentares estão fortemente envolvidos em todo o processo de desenvolvimento do produto, desde a ideia inicial ao final do seu ciclo de vida. Tendo em conta a variedade de atividades com as quais tive oportunidade de lidar, ao longo deste relatório incluí a minha perspetiva em relação à natureza multidisciplinar que envolve a temática dos Assuntos Regulamentares.
This report describes the activities performed as a trainee in the Regulatory Strategy and Regulatory Affairs department of Eurotrials, Scientific Consultants, a company specialized in clinical research and scientific consultancy in the area of health. The main objective of this 9-month experience was the first contact with the employment world, with consolidation and deeper understanding of the contents approached in the Master in Pharmaceutical Biomedicine. Regulatory Affairs are strongly involved in the entire process of the product development, since the initial idea to the end of its life-cycle. Taking into account the variety of activities I had the opportunity to deal with, in the course of this report I included my own perspective regarding the multidisciplinary nature of Regulatory Affairs.
APA, Harvard, Vancouver, ISO, and other styles
7

Martin, Kelly M. "Are disinfection by-products in tapwater associated with intrauterine growth retardation?" Thesis, McGill University, 2000. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=31269.

Full text
Abstract:
Introduction. Chlorination of surface water for human consumption results in a number of potentially toxic by-products. Recent investigation of the effects of these by-products on reproductive outcomes has demonstrated small increases in the risk of both intrauterine growth retardation and low birthweight with increasing exposure.
Objective. The primary objective of this study was to examine the relationship between one group of disinfection by-products, trihalomethanes, and intrauterine growth retardation. The secondary objective was to compare the relationship found with the commonly used estimate of exposure, THM concentration, to that found with aggregate exposure measures.
Methods. A case-control study was carried out with 200 cases and 200 matched controls. The risk of THM exposure was estimated using conditional logistic regression, controlling for the confounding effect of maternal smoking, prepregnancy weight and education.
Results. A small, but imprecise, increase in the risk of IUGR was found with increasing levels of the brominated THMs, particularly bromoform. A decrease in the odds ratio was observed with increasing exposure information in the aggregate measures.
Conclusions. The results of this study support previous studies demonstrating a relationship between THMs and intrauterine growth retardation, particularly the brominated THMs. However, the small sample size does not allow any firm conclusions to be drawn about this relationship.
APA, Harvard, Vancouver, ISO, and other styles
8

Wang, Tao 1958. "Prostaglandins and lipid peroxidation products in atherosclerosis." Thesis, McGill University, 1992. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=70253.

Full text
Abstract:
Lipid peroxidation has been implicated in the development of atherosclerosis. It is responsible for modification of low density lipoprotein (LDL), injury to endothelial cells and has been reported to alter prostacyclin synthesis. We therefore investigated lipid peroxidation in human LDL and in LDL and aortae from rabbits fed cholesterol-supplemented diets. We also studied the correlation between lipid peroxidation and prostanoid production in vivo and in vitro.
Unsaturated fatty acids in human LDL are oxidized to their monohydroxy derivatives during the incubation with CuSO$ sb4$ and endothelial cells. Gas chromatographic-mass spectrometric analysis of monohydroxy fatty acids revealed a similar mechanism of peroxidation of LDL lipids by endothelial cells as that by CuSO$ sb4,$ i.e., autooxidation of LDL lipids.
Increased amounts of monohydroxy fatty acids in LDL and aorta were observed in rabbits fed cholesterol-supplemented diets. The increased amounts of monohydroxy derivatives of oleic and linoleic acids, but not those of arachidonic acid, were due to the increased amounts of their fatty acid precursors. The increased amounts of aortic monohydroxy derivatives of arachidonic acid, but not those of oleic and linoleic acids, were positively correlated with the severity of the atherosclerotic lesions.
Prostacyclin production by aortae was slightly increased after cholesterol-supplemental diets despite evidence for increased lipid peroxidation in this tissue. This may be because esterified hydroperoxy fatty acids in aorta are not very effective in inhibiting prostaglandin synthesis. In contrast to the moderate changes in aortic PGI$ sb2$ synthesis, there was a dramatic increase in the synthesis of thromboxane B$ sb2$ by aortae from hypercholesterolemic rabbits, suggesting a role for thromboxane A$ sb2$ in atherogenesis.
APA, Harvard, Vancouver, ISO, and other styles
9

Sarna, Lindsei. "Regulation of oxidative stress and its modulation by natural health products." NRC Research Press, 2010. http://hdl.handle.net/1993/30624.

Full text
Abstract:
Oxidative stress is characterized by the cellular accumulation of reactive oxygen species (ROS). Increased production of ROS, such as the superoxide anion (O2.-), or a deficiency in their clearance by antioxidant defenses, mediates the cellular pathology. Non-alcoholic fatty liver disease (NAFLD) is a broad spectrum liver disorder commonly manifesting in milieu of the metabolic syndrome. Oxidative stress is an important pathogenic mediator in NAFLD, and in its associated morbidities like atherosclerosis. The objective of my research was to investigate the regulation of oxidative stress and the antioxidant actions of natural health products (NHPs) in the context of NAFLD and its associated disorders. The O2.- generating NADPH oxidase contributes to atherogenesis by facilitating macrophage induced vascular injury. In manuscript I, the plant alkaloid berberine effectively abolished NADPH oxidase mediated O2.- production in lipopolysaccharide stimulated macrophages. Real-time PCR analysis and siRNA transfection studies revealed that berberine mediated its effects through down-regulation of the oxidase’s catalytic subunit gp91phox. Berberine also restored the activity of the O2.- clearing enzyme superoxide dismutase (SOD). High fat diet (HFD) fed rodents are a popular model for investigating NAFLD pathogenesis. In manuscript II, folic acid supplementation significantly reduced HFD-induced hepatic oxidative stress and liver injury in mice. Folic acid decreased NF-kB/DNA binding, down-regulated NADPH oxidase gene expression, and inhibited the oxidase. The antioxidant activities of SOD and catalase were restored and the reduced to oxidized glutathione ratio (GSH:GSSG) was re-established with folic acid supplementation. Folic acid’s hepatoprotective antioxidant effects were associated with a marked improvement in liver histology. Homocysteine (Hcy) levels are perturbed in NAFLD, but the etiology is unclear. In manuscript III, HFD fed mice exhibited decreased Hcy levels. Real-time PCR and Western Immunoblotting analysis revealed that Hcy catabolising enzymes cystathionine-b-synthase (CBS) and cystathionine-g-lyase (CSE) were increased in the liver of these animals. The transsulfuration activities of these enzymes were elevated and coincided with enhanced hepatic hydrogen sulfide biosynthesis. Glutathione was maintained despite increased hepatic oxidative stress. Taken together, NHPs such as berberine and folate, and Hcy catabolising enzymes CBS and CSE, might have therapeutic potential for managing oxidative stress in NAFLD and its associated co-morbidities.
October 2015
APA, Harvard, Vancouver, ISO, and other styles
10

Pagano, Imma. "Bioactives from agricultural food by-products: application in food and health." Doctoral thesis, Universita degli studi di Salerno, 2017. http://hdl.handle.net/10556/2556.

Full text
Abstract:
2015 - 2016
Agriculture and agri-food industry produce a large amount of residues in non-edible portions from cultivation and processing of crops. These wastes, considered by-products, give serious environment damage, if not properly disposed, also because of their seasonal production. Until a few years ago the only goal was the disposal of these by-products. Recently the researchers discovered the characteristics of these wastes and their possible exploitation as sources of interesting compounds and energy for pharmaceutical, cosmetics and nutraceutical sectors. Fruit and vegetable by-products, in fact, are rich in bioactive compounds, such as carotenoids, dietary fibers, minerals and phenolic compounds, with correlated beneficial health effects. In this context the activity of the PhD project evaluated agricultural by-products as sources of bioactive compounds. The aims of the present PhD project were the development of innovative and selective analytical methodologies, for determination of bioactive compounds, using liquid chromatography methods (UHPLC) coupled to UV-Vis spectroscopy and mass spectrometry (high resolution, HRMS and tandem mass, MS/MS), the improvement of new extraction techniques, which can optimize extraction yields, minimize costs and environmental impact, such as pressurized hot water extraction (PHWE), ultrasound assisted extraction (UAE) and supercritical antisolvent fractionation (SAF), and finally the study of antioxidant activity of obtained extracts, using chemical and biological assays (DPPH, ABTS, ORAC, CAA). The analysis of bioactive compounds in plant extracts through advanced sample preparation techniques and modern separation tools allows a comprehensive study of the matrix. The project, very relevant, was to provide innovative methodologies, procedures and final products for different companies of healthcare area, in terms of innovation, costs and profits. The project was divided into three major areas, corresponding to the three selected by-products. The determination of chemical profile and the development and optimization of innovative and green extraction procedure for recovery of bioactive compounds have been carried out for each matrix. Selected by-products were: the main artichoke by-products, bracts and leaves, derived from cultivation and industrial processing, hazelnut by-products, roasted skins, derived from kernel industrial processing, and aromatic plants by-products, distillation waste waters, derived from essential oils production. All by-products studied have proved to be low cost sources of bioactive compounds with antioxidant activity. Furthermore, among innovative extraction techniques, PHWE procedures have allowed obtaining final extracts selectively rich in compounds of interest without formation of artefacts, and compared to existing extraction methods were simple, fast, environmentally friendly and fully automated. Moreover my PhD project provided new analytical methods to standardize vegetable extracts. The most relevant results showed that discarded raw materials are suitable ingredients for the production of formulated health products and nutraceuticals. [edited by author]
XV n.s. (XXIX)
APA, Harvard, Vancouver, ISO, and other styles

Books on the topic "Health products"

1

Federation, International Dairy, ed. Milk products and health. Brussels: International Dairy Federation, 1987.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Santon, June. Animal health care products. Norwalk, CT: Business Communications Co., 1997.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Rinzler, Carol Ann. The women's health products handbook. 2nd ed. Alameda, CA: Hunter House, 1997.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Myanmar Marketing Research & Development., ed. Health products directory, 2003-2004. [Yangon: MMRD Publications Services, 2004.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

(Firm), Find/SVP, ed. Home health care products & services. New York, N.Y: FIND/SVP, 1987.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

National Library of Medicine (U.S.). Specialized Information Services Division., ed. Household products database: Health & safety information on household products. Bethesda, MD: Specialized Information Services, U.S. National Library of Medicine, National Institutes of Health, Dept. of Health & Human Services, 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Rathbone, Michael J., and Arlene McDowell, eds. Long Acting Animal Health Drug Products. New York, NY: Springer US, 2012. http://dx.doi.org/10.1007/978-1-4614-4439-8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Ahmad, Saghir, and Nasser Abdulatif Al-Shabib, eds. Functional Food Products and Sustainable Health. Singapore: Springer Singapore, 2020. http://dx.doi.org/10.1007/978-981-15-4716-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Inc, Medical Data International, ed. U.S. women's health products and markets. Irvine, Calif: Medical Data International, 1998.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Canada. Natural Health Products Directorate. Clinical trials for natural health products. [Ottawa]: Natural Health Products Directorate, Health Canada, 2005.

Find full text
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Health products"

1

Hignett, Sue. "Products." In Design for Health, 154–69. Abingdon, Oxon ; New York, NY : Routledge, 2017. |: Routledge, 2017. http://dx.doi.org/10.4324/9781315576619-10.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Paterson, Abby, Richard Bibb, K. Downey, and Jari Pallari. "Products." In Design for Health, 241–59. Abingdon, Oxon ; New York, NY : Routledge, 2017. |: Routledge, 2017. http://dx.doi.org/10.4324/9781315576619-15.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Macdonald, Alastair S. "Products." In Design for Health, 311–27. Abingdon, Oxon ; New York, NY : Routledge, 2017. |: Routledge, 2017. http://dx.doi.org/10.4324/9781315576619-19.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Pitacco, Ermanno. "Health Insurance Products." In Health Insurance, 29–62. Cham: Springer International Publishing, 2014. http://dx.doi.org/10.1007/978-3-319-12235-9_3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Roberts, Elizabeth. "Animal Health Products." In Regulatory Toxicology, 67–82. Third edition. | Boca Raton, Florida : CRC Press, [2019]: CRC Press, 2018. http://dx.doi.org/10.1201/9780429464737-3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Billah, Mohd Ma’Sum. "Health Takaful Rider Plan." In Islamic Insurance Products, 147–57. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-17681-5_10.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Johnson, Barry L., and Maureen Y. Lichtveld. "Tobacco Products." In Environmental Policy and Public Health, 159–87. Second edition. | Boca Raton : Taylor & Francis, 2017. | “A CRC title, part of the Taylor & Francis imprint, a member of the Taylor & Francis Group, the academic division of T&F Informa plc.”: CRC Press, 2017. http://dx.doi.org/10.1201/9781351228473-7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Ottogalli, Giorgio, and Giulio Testolin. "Dairy Products." In The Mediterranean Diets in Health and Disease, 135–59. Boston, MA: Springer US, 1991. http://dx.doi.org/10.1007/978-1-4684-6497-9_7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Billah, Mohd Ma’Sum. "Group Takaful Plan for Health Care." In Islamic Insurance Products, 167–80. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-17681-5_12.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Tabuchi, Takahiro. "Health Effect." In Science and Practice for Heated Tobacco Products, 55–62. Singapore: Springer Singapore, 2021. http://dx.doi.org/10.1007/978-981-33-4504-1_6.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Health products"

1

Beattie, P. J., W. H. Krebs, and B. H. Strohm. "Petroleum Products and Employee Health." In 1986 SAE International Fall Fuels and Lubricants Meeting and Exhibition. 400 Commonwealth Drive, Warrendale, PA, United States: SAE International, 1986. http://dx.doi.org/10.4271/861597.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Đonović, Nela, Sanja Kocić, and Svetlana Radević. "HEALTH SAFETY OF BAKERY PRODUCTS." In 2nd International Symposium on Biotechnology. University of Kragujevac, Faculty of Agronomy, 2024. http://dx.doi.org/10.46793/sbt29.40ndj.

Full text
Abstract:
Nutrition is the main factor in people’s health. Food can be both a resource and a great hazard to the health of the entire population. The Institute for Public Health Kragujevac is an accredited institution for food analysis. In 2023, 472 samples of bakery products were sampled and analyzed; 469 products (99.36%) were microbiologically safe and 460 products (97.45%) were chemically compliant. The increased yeast content was the microbiological reason for the unsoundness of the two bakery products. Recommended measures: to increase the scope of testing in both microbiological and chemical aspects, by supplementing the current regulations.
APA, Harvard, Vancouver, ISO, and other styles
3

Popov, V., V. Tomenko, C. A. Brebbia, A. H. Piersma, and M. Luijten. "Risk assessment for pharmaceutical products in the environment." In Environmental Health Risk 2005. Southampton, UK: WIT Press, 2005. http://dx.doi.org/10.2495/ehr050011.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Gu, Jie, Daniel Lau, and Michael Pecht. "Health assessment and prognostics of electronic products." In 2009 8th International Conference on Reliability, Maintainability and Safety (ICRMS 2009). IEEE, 2009. http://dx.doi.org/10.1109/icrms.2009.5269967.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Rigby, M. "The risks of products in health informatics." In 3rd IET International Conference on Medical Electrical Devices and Technology (MEDTECH 2007). IET, 2007. http://dx.doi.org/10.1049/ic.2007.1689.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Farah, Adriana. "Coffee By-Products for Sustainable Health Promotion." In ICC 2023. Basel Switzerland: MDPI, 2023. http://dx.doi.org/10.3390/icc2023-14845.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Coventry, K. "Regulatory Considerations for Natural Health Product & Functional Food Commercialization in the North American Health Products Marketplace." In Abstracts of the NHPRS – The 15th Annual Meeting of the Natural Health Products Research Society of Canada (NHPRS). Georg Thieme Verlag KG, 2018. http://dx.doi.org/10.1055/s-0038-1644975.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

MOON, HOYEON, HWEEKWON JUNG, YESEUL KONG, and GYUHAE PARK. "Assessment of Pressed Panel Products using Camera Image Processing." In Structural Health Monitoring 2017. Lancaster, PA: DEStech Publications, Inc., 2017. http://dx.doi.org/10.12783/shm2017/14220.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Morain, S., and A. Budge. "Science Data Products for Public Health Decision Support." In 2006 IEEE International Symposium on Geoscience and Remote Sensing. IEEE, 2006. http://dx.doi.org/10.1109/igarss.2006.112.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Bergman, S., and J. Meline. "463. Screen Reclamation Products: Reducing Exposure and Risk." In AIHce 1996 - Health Care Industries Papers. AIHA, 1999. http://dx.doi.org/10.3320/1.2765150.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Health products"

1

Ma, Yoon Jin, and Jinseok Kim. Online Review Mining: Health and Environmental Concerns on Beauty Products. Ames: Iowa State University, Digital Repository, 2017. http://dx.doi.org/10.31274/itaa_proceedings-180814-1864.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Rycroft, Taylor, Sabrina Larkin, Alexander Ganin, Treye Thomas, Joanna Matheson, Tessa Van Grack, Xinrong Chen, Kenton Plourde, Alan Kennedy, and Igor Linkov. A framework and pilot tool for the risk-based prioritization and grouping of nano-enabled consumer products. Engineer Research and Development Center (U.S.), August 2021. http://dx.doi.org/10.21079/11681/41721.

Full text
Abstract:
The use of engineered nanomaterials (ENMs) in consumer products has expanded rapidly, revealing both innovative improvements over conventional materials, and the potential for novel risks to human health and the environment. As the number of new nano-enabled products and the volume of toxicity data on ENMs continues to grow, regulatory agencies like the U.S. Consumer Product Safety Commission (CPSC) – a small, independent federal agency responsible for protecting consumers from unreasonable risks associated with product use – will require the ability to screen and group a diverse array of nano-enabled consumer products based on their potential risks to consumers. Such prioritization would allow efficient allocation of limited resources for subsequent testing and evaluation of high-risk products and materials. To enable this grouping and prioritization for further testing, we developed a framework that establishes a prioritization score by evaluating a nano-enabled product's potential hazard and exposure, as well as additional consideration of regulatory importance. We integrate the framework into a pilot version software tool and, using a hypothetical case study, we demonstrate that the tool can effectively rank nano-enabled consumer products and can be adjusted for use by agencies with different priorities. The proposed decision-analytical framework and pilot-version tool presented here could enable a regulatory agency like the CPSC to triage reported safety concerns more effectively and allocate limited resources more efficiently.
APA, Harvard, Vancouver, ISO, and other styles
3

Meredith, Jennifer, Jonathan Robinson, Sarah Walker, and Bruce Wydick. Keeping the Doctor Away: Experimental Evidence on Investment in Preventative Health Products. Cambridge, MA: National Bureau of Economic Research, August 2013. http://dx.doi.org/10.3386/w19312.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

van Asselt, E. D., N. Dam, I. Gielen, S. Sasse, R. Wegh, and M. G. Pikkemaat. Grey zone products with animal health or biocidal claims in poultry production. Wageningen: Wageningen Food Safety Research, 2023. http://dx.doi.org/10.18174/654533.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Kuperman, Roman G., Ronald T. Checkai, and Nancy A. Chester. Review of Literature on Health Effects of Corn Oil and Its Oxidation Products. Fort Belvoir, VA: Defense Technical Information Center, April 2011. http://dx.doi.org/10.21236/ada543372.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Fischer, Greg, Dean Karlan, Margaret McConnell, and Pia Raffler. To Charge or Not to Charge: Evidence from a Health Products Experiment in Uganda. Cambridge, MA: National Bureau of Economic Research, May 2014. http://dx.doi.org/10.3386/w20170.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Avery, Rosemary, Donald Kenkel, Dean Lillard, and Alan Mathios. Private Profits and Public Health: Does Advertising Smoking Cessation Products Encourage Smokers to Quit? Cambridge, MA: National Bureau of Economic Research, January 2006. http://dx.doi.org/10.3386/w11938.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Katie D McMillan, Katie D. McMillan. What is known about the efficacy and safety of tech products for reproductive health? Experiment, March 2022. http://dx.doi.org/10.18258/25247.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Risk Assessment Unit. Animal product imports project: public health expert opinion elicitation. Food Standards Agency, June 2024. http://dx.doi.org/10.46756/sci.fsa.aye787.

Full text
Abstract:
An expert opinion elicitation exercise was held in order to estimate the relative public health risk associated with 19 categories of imported Products of Animal Origin (POAO) in terms of relevant microbiological pathogens, biotoxins and chemical contaminants.
APA, Harvard, Vancouver, ISO, and other styles
10

Gindi, Renee. Health, United States, 2019. Centers for Disease Control and Prevention (U.S.), 2021. http://dx.doi.org/10.15620/cdc:100685.

Full text
Abstract:
Health, United States, 2019 is the 43rd report on the health status of the nation and is submitted by the Secretary of the Department of Health and Human Services to the President and the Congress of the United States in compliance with Section 308 of the Public Health Service Act. This report was compiled by the National Center for Health Statistics (NCHS) of the Centers for Disease Control and Prevention (CDC). The Health, United States series presents an annual overview of national trends in key health indicators. The 2019 report presents trends and current information on selected measures of morbidity, mortality, health care utilization and access, health risk factors, prevention, health insurance, and personal health care expenditures in a 20-figure chartbook. The Health, United States, 2019 Chartbook is supplemented by several other products including Trend Tables, an At-a-Glance table, and Appendixes available for download on the Health, United States website at: https://www.cdc.gov/nchs/hus/ index.htm. The Health, United States, 2019 Chartbook contains 20 figures and 20 tables on health and health care in the United States. Examining trends in health informs the development, implementation, and evaluation of health policies and programs. The first section (Figures 1–13) focuses on health status and determinants: life expectancy, infant mortality, selected causes of death, overdose deaths, suicide, maternal mortality, teen births, preterm births, use of tobacco products, asthma, hypertension, heart disease and cancer, and functional limitations. The second section (Figures 14–15) presents trends in health care utilization: use of mammography and colorectal tests and unmet medical needs. The third section (Figures 16–17) focuses on health care resources: availability of physicians and dentists. The fourth section (Figures 18–20) describes trends in personal health care expenditures, health insurance coverage, and supplemental insurance coverage among Medicare beneficiaries. The Highlights section summarizes major findings from the Chartbook. Suggested citation: National Center for Health Statistics. Health, United States, 2019. Hyattsville, MD. 2021.
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography